La vendita allo scoperto per Citius Pharmaceuticals dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Citius Pharmaceuticals. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Citius Pharmaceuticals (NASDAQ:CTXR) Azioni, Report sulle vendite allo scoperto

CITIUS PHARMACEUTICALS INC

Citius Pharma

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

News

Pre-Market Outlook

Markets

Trading Ideas

$LUNA

CCTG

CTXR

LUNA

Oggi alcuni titoli azionari stanno attirando particolare attenzione nel pre-market a causa di annunci chiave e movimenti significativi.

Pre-market: 5 titoli da monitorare oggi, 30 dicembre 2024

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals Inc

Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has outperformed the market over the past 10 years by 12.75% on an annualized basis producing an average annual return of 24.16%. Currently, Eli Lilly has a market capitalization of $693.38 billion. 
Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 10 years ago, it would be worth $8,701.53 today based on a price of $771.99 for LLY at the time of writing.
<h3>Eli Lilly's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751929214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

The celebration of America's 250th birthday is less than a year away and work is already being done on the planning for<a href="https://www.benzinga.com/news/politics/25/06/45894541/trump-sports-president-military-birthday-parade"> the country's semiquincentennial.</a>
Sports fans could get treated to live events happening at the White House on July 4, 2026, and in a different U.S. city to celebrate the historic American anniversary.
UFC at White House Proposed: President Donald Trump has been a<a href="https://www.benzinga.com/news/24/08/40298813/trump-snaps-back-at-joe-rogan-asking-how-loudly-hed-get-booed-when-he-enters-ufc-ring-next-time-afte"> big fan of the UFC,</a> the mixed martial arts company owned by TKO Group Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>), for years.
The president recently said that he was considering hosting a UFC fight at the White House as part of America's 250th anniversary celebration. The UFC <a href="https://frontofficesports.com/ufc-confirms-talks-to-bring-fight-to-white-house-grounds/">confirmed </a>to Front Office Sports that the discussions are real and underway.
July 4, 2026, will mark the 250th anniversary of the signing of the Declaration of Independence and watching professional fighters beat each other up at the White House could be one of the key celebrations for Americans across the country.
UFC has taken part in fights around the world in unique venues, but creating an Octagon inside or outside the White House could be among the biggest challenges yet. A UFC fight would also mark the first pro sports event hosted at the White House if the talks lead to an official event.
Read Also: <a href="https://www.benzinga.com/news/politics/25/06/45934225/big-tech-companies-helped-fund-trumps-inauguration-now-they-could-be-funding-his-military-birthday-parade">Big Tech Companies Helped Fund Trump&#8217;s Inauguration, Now They Could Be Funding His Military, Birthday Parade</a>
U.S. Soccer Celebration: The U.S. Men's National Soccer Team is one of several co-hosts for the 2026 World Cup and has already qualified for the tournament as a result.
This year's World Cup will feature 48 teams for the first time, as opposed to the 32 that have been included every four years in recent tournament history. The top two teams of each group (12 groups) along with the eight best third-place teams will qualify for the Round of 32.
It is currently unknown which group Team USA will be part of. If they manage to make it past their group and into the Round of 32, they could set up a huge American anniversary celebration.
Two of the Round of 16 games will be <a href="https://www.fifa.com/en/tournaments/mens/worldcup/canadamexicousa2026/articles/match-schedule-fixtures-results-teams-stadiums">played </a>on July 4, 2026, with one played in Houston and one played in Philadelphia. While neither game will take place in Washington, D.C., as American sports go, this could be one of the biggest in Team USA history.
The U.S. Men's National Soccer Team previously <a href="https://www.ussoccer.com/stories/2024/07/finals-bound-on-the-fourth">played </a>on July 4, 1994, losing 1-0 to Brazil in the Round of 16. The U.S. Women's National Soccer Team previously played on July 4, 1999, defeating Brazil 2-0 in the semifinals to advance to the tournament final.
Neither of those events happened during a huge anniversary year like the potential of Team USA playing on the country's semiquincentennial.
Of course, to make it to the Round of 16, Team USA may have to be playing better than recent matches, after losing the Gold Cup final to Mexico over the Fourth of July weekend this year. Team USA is currently ranked with the 13th best odds to win the World Cup at DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) at +4,000.
Fox Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>), which has the U.S. rights to the 2026 World Cup games, is likely to see strong viewership the longer Team USA is in it.
While it's a year away and logistics need to be worked out and Team USA needs to make the right Round of 16 game, there is the possibility that sports fans get to watch<a href="https://www.benzinga.com/news/sports-betting/25/06/45983571/joey-chestnut-the-goat-returns-after-16-hot-dog-titles-can-anyone-stop-him"> Joey Chestnut eat hot dogs</a>, Team USA win a World Cup Round of 16 game and watch UFC fighters compete in a White House Octagon all on the country's birthday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/sports/25/05/45634051/tesla-cybertruck-demand-slides-but-mexican-police-fleet-buying-for-2026-fifa-world-cup">Tesla Cybertruck Demand Slides, But Mexican Police Fleet Buying For 2026 FIFA World Cup</a></li>
</ul>
Photos: Shutterstock

Government

Politics

Sports

General

DKNG

FOXA

Trump Wants UFC Fight At White House For Semiquincentennial, Could USA Soccer Also Play On Country's 250th Anniversary?

Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has outperformed the market over the past 15 years by 31.98% on an annualized basis producing an average annual return of 44.23%. Currently, Tesla has a market capitalization of $948.25 billion. 
Buying $1000 In TSLA: If an investor had bought $1000 of TSLA stock 15 years ago, it would be worth $258,598.24 today based on a price of $294.40 for TSLA at the time of writing.
<h3>Tesla's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751928312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TSLA

Here's How Much $1000 Invested In Tesla 15 Years Ago Would Be Worth Today

IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) has outperformed the market over the past 20 years by 2.86% on an annualized basis producing an average annual return of 11.3%. Currently, IDEXX Laboratories has a market capitalization of $44.21 billion. 
Buying $100 In IDXX: If an investor had bought $100 of IDXX stock 20 years ago, it would be worth $857.66 today based on a price of $545.56 for IDXX at the time of writing.
<h3>IDEXX Laboratories's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751927412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IDXX

Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years

For years, cable television has dominated the ratings for one week in summer with Warner Bros. Discovery's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) "Shark Week." The company's stranglehold on <a href="https://www.benzinga.com/25/05/45298158/warner-bros-stock-falls-as-weak-studio-ad-sales-weigh-on-q1-despite-streaming-gains">summer shark content </a>could be coming to an end with streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) taking a bite out of the popular ocean content.
What Happened: Fans of Discovery Channel and "Shark Week" are waiting until later this month, July 20-26, to view content that's part of the 37th annual Shark Week. Ahead of this content, consumers have options to watch shark-themed content from <a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering">streaming giant Netflix</a> and another cable company.
Netflix launched "All the Sharks," a new reality competition on July 4. The series features four teams of shark experts who try to photograph the most different shark types before the end of the competition, as <a href="https://www.hollywoodreporter.com/tv/tv-features/netflix-shark-whisperer-vs-shark-week-sharkfest-1236303707/">reported </a>by The Hollywood Reporter.
The streaming company also premiered "Shark Whisperer," a documentary that has ranked among the streamer's top 10 most-watched films every day.
Netflix will also have the streaming rights for the four "Jaws" films starting on July 15, with the first film recently celebrating its 50th anniversary this summer.
SharkFest kicked off on July 5 with "Sharks Up Close With Bertie Gregory." SharkFest is in its 13th season as an annual tradition of shark content from the National Geographic Channel, which is 83% owned by Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>).
SharkFest will have more hours than normal through July 13 with 25 hours, throwing another potential challenge for Shark Week.
Read Also: <a href="https://www.benzinga.com/news/entertainment/25/07/46250106/this-is-netflixs-next-big-bet-after-squid-game-stranger-things">This Is Netflix&#8217;s Next Big Bet After &#8216;Squid Game,&#8217; &#8216;Stranger Things&#8217;</a>
Why It's Important: With Netflix's push for shark content and SharkFest growing, what once was a dominant week of content for Warner Bros. Discovery could now face viewer fatigue.
Content during these shark weeks of summer have done well for cable television and could now face the challenge of fending off Netflix, who got a head start on the race.
Last year, SharkFest had over 69 million views on content, including on National Geographic and through streaming on Disney+ and Hulu.
Last year's Shark Week had over 25 million views for content on Discovery Channel and streaming on Discovery+ and MAX.
Content for Shark Week ranked strong in the key age 25-54 demographic, with the shark content placing in seven of the top 10 spots for the week for the age 25-54 demo for ad-supported cable, excluding news and sports.
News of Netflix taking SharkFest and Shark Week head on comes <a href="https://www.benzinga.com/news/entertainment/25/06/45978982/streaming-dethrones-tv-giants-netflix-youtube-lead-the-takeover">after streaming viewership </a>for the month of May surpassed the total of broadcast and cable television combined for the first time ever with a 44.8% market share to 44.2% market share, according to Nielsen data.
The remaining 10.9% was listed as miscellaneous categories.
Netflix continues to dominate streaming and is getting closer to disrupting all the major content wins of broadcast and cable television with entries in live sports, awards shows, reality television, shark content and more.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46210996/netflixs-squid-game-ends-or-does-it">Netflix&#8217;s &#8216;Squid Game&#8217; Ends&#8230; Or Does It?</a></li>
</ul>
Image: Lucky Step via Shutterstock

Entertainment

Media

NFLX

Netflix Quietly Circles Shark Week With A Killer Strategy

Allied Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) reported quarterly losses of $(0.11) per share. This is a 175 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $2.275 million in sales this quarter. This is a 4.37 percent decrease over sales of $2.379 million the same period last year.

Earnings

AGAE

Allied Gaming Q1 EPS $(0.11) Down From $(0.04) YoY, Sales $2.275M Down From $2.379M YoY

Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) has outperformed the market over the past 5 years by 4.3% on an annualized basis producing an average annual return of 18.64%. Currently, Netflix has a market capitalization of $548.83 billion. 
Buying $100 In NFLX: If an investor had bought $100 of NFLX stock 5 years ago, it would be worth $253.98 today based on a price of $1289.62 for NFLX at the time of writing.
<h3>Netflix's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751926520_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Netflix 5 Years Ago Would Be Worth This Much Today

Correction: The current prime minister of Japan is Shigeru Ishiba, not Fumio Kishida. 
The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting <a href="https://www.benzinga.com/markets/equities/25/07/46281204/wall-street-today-trump-tariffs-japan-south-korea-stocks-drop">multiple U.S. trading partners.</a>
Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a 25% tariff, Trump announced Monday, citing persistent trade imbalances and unfair practices.
The move follows a 90-day pause for negotiations that fell short of providing a better outcome than the &#8220;Liberation Day&#8221; duties on April 2. And now, the fallout is landing hard.
The dollar surged past 146 yen, gaining 1.2% on the day—its sharpest move since May 12. 
<h3 class="wp-block-heading">Markets Shake As White House Sends Tariff Letters To Trading Partners</h3>
In an official letter to Japanese Prime Minister Shigeru Ishiba, Trump stated that the new tariffs aim to address what he called "years of Japan&#8217;s tariff and non-tariff policies and trade barriers."
He also warned that any retaliatory tariffs would be met with proportional increases by the U.S. and said transshipped goods would face higher rates. 
He also offered an out: Japanese companies that move production to the U.S. won't face tariffs — and he promised quick approvals for those who do.
According to International Trade Statistics data, U.S. imports from Japan totaled $152.07 billion in 2024, with vehicles accounting for $51.27 billion and machinery, including nuclear reactors and boilers, adding another $36.05 billion.
The White House stated that the tariff levels could be revised based on bilateral trade relationships, with the goal of reducing trade deficits and protecting U.S. national security.
<h3 class="wp-block-heading">More Countries Face Tariff Hikes</h3>
South Korea will also face a 25% tariff starting in August under the same terms as Japan. The dollar gained 0.9% against the Korean won in the session, reinforcing the greenback's strength amid heightened global tensions.
Several other countries were also named in the tariff list, including:
<ul class="wp-block-list">
<li>Malaysia: 25% tariff</li>
<li>South Africa: 30% tariff;</li>
<li>Kazakhstan: 25% tariff,</li>
<li>Laos and Myanmar: 40% tariffs</li>
</ul>
<h3 class="wp-block-heading">ETFs Took A Beating</h3>
Country-focused ETFs sold off hard on Monday: 
<ul class="wp-block-list">
<li>The iShares MSCI Japan ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWJ#NYSE">EWJ</a>) dropped 2.3%, marking its worst session since April 10. That's a sharp reversal after a 25% rally off spring lows.</li>
<li>The iShares MSCI South Korea ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWY#NYSE">EWY</a>) plunged 3.5%, also its worst day since early April.</li>
<li>The iShares MSCI Malaysia ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWM#NYSE">EWM</a>) fell 2%.</li>
<li>The iShares MSCI South Africa ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EZA#NYSE">EZA</a>) dropped 2%.</li>
</ul>
<h3 class="wp-block-heading">What's Next?</h3>
The White House said tariffs could still be adjusted — higher or lower — depending on "the strength of the relationship" with each country.
Investors are now watching closely to see how Japan, South Korea, and others respond — and whether the European Union, facing a similar deadline this week, becomes the next target in Trump's escalating trade war.
Meanwhile, the message from markets is clear: tariffs are back in play, and traders are bracing for more volatility ahead.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46280221/vice-stocks-beat-esg-trump-2025">Guns, Booze, And Gambling Stocks Are Crushing ESG In Trump&#8217;s America</a></li>
</ul>
Photo: Shutterstock

Asia

Equities

Macro Economic Events

Regulations

Emerging Markets

Emerging Market ETFs

Econ #s

Economics

ETFs

Trump's Surprise Tariffs Just Crushed Japan's Stocks, Yen And More (CORRECTED)

4 analysts have expressed a variety of opinions on BKV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKV#NYSE">BKV</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $28.25, a high estimate of $30.00, and a low estimate of $26.00. Marking an increase of 5.61%, the current average surpasses the previous average price target of $26.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1751925672_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive BKV. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Stephen Richardson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$28.00</td>
<td>$30.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to BKV. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of BKV compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for BKV's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of BKV's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BKV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on BKV analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know BKV Better</h2>
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).
<h3>BKV: Delving into Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining BKV's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 48.57% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -34.55%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): BKV's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -5.17%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): BKV's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.51%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.13.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Expert Outlook: BKV Through The Eyes Of 4 Analysts

Throughout the last three months, 27 analysts have evaluated Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">12</td>
<td align="right">5</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $288.46, with a high estimate of $510.00 and a low estimate of $180.00. Marking an increase of 4.93%, the current average surpasses the previous average price target of $274.92. 
<img src="https://www.benzinga.com/files/images/story/2025/1751925651_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Coinbase Global's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$268.00</td>
<td>$239.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$395.00</td>
<td>$293.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$400.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Gautam Chhugani</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$510.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$421.00</td>
<td>$301.00</td>
</tr>
<tr>
<td>Cindy Wang</td>
<td>China Renaissance</td>
<td>Announces</td>
<td>Buy</td>
<td>$353.30</td>
<td>-</td>
</tr>
<tr>
<td>Chris Brendler</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Trevor Williams</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$260.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$301.00</td>
<td>$252.00</td>
</tr>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$239.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Chris Brendler</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$300.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$293.00</td>
<td>$269.00</td>
</tr>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$209.00</td>
<td>$189.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$202.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Chris Brendler</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$260.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>John Todaro</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$215.00</td>
<td>$276.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$269.00</td>
<td>$279.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$205.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$400.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Peter Christiansen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$276.00</td>
<td>$344.00</td>
</tr>
<tr>
<td>Chris Brendler</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$260.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Ed Engel</td>
<td>Compass Point</td>
<td>Announces</td>
<td>Sell</td>
<td>$180.00</td>
<td>-</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Announces</td>
<td>Buy</td>
<td>$252.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Brendler</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$290.00</td>
<td>$305.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Coinbase Global. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coinbase Global compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Coinbase Global's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Coinbase Global's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/COIN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Coinbase Global analyst ratings.</a>
<h2>All You Need to Know About Coinbase Global</h2>
Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange. While the company still generates the majority of its revenue from transaction fees charged to its retail customers, Coinbase uses internal investment and acquisitions to expand into adjacent businesses, such as prime brokerage and data analytics.
<h3>Coinbase Global: Delving into Financials</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Coinbase Global's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 24.23%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Coinbase Global's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 3.23%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Coinbase Global's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.63%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Coinbase Global's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.3%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Coinbase Global's debt-to-equity ratio is below the industry average. With a ratio of 0.41, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COIN

Demystifying Coinbase Global: Insights From 27 Analyst Reviews

During the last three months, 13 analysts shared their evaluations of Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>), revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Coterra Energy and provided 12-month price targets. The average target is $33.77, accompanied by a high estimate of $37.00 and a low estimate of $30.00. A 3.51% drop is evident in the current average compared to the previous average price target of $35.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1751925639_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Coterra Energy by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$31.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$36.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$36.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$32.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$33.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coterra Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coterra Energy compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Coterra Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Coterra Energy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CTRA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Coterra Energy analyst ratings.</a>
<h2>Discovering Coterra Energy: A Closer Look</h2>
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.
<h3>Unraveling the Financial Story of Coterra Energy</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Coterra Energy's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 32.87% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: Coterra Energy's net margin excels beyond industry benchmarks, reaching 27.1%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Coterra Energy's ROE excels beyond industry benchmarks, reaching 3.77%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Coterra Energy's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.26%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.32, Coterra Energy adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTRA

Coterra Energy Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)

In the latest quarter, 8 analysts provided ratings for Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Allstate, revealing an average target of $216.88, a high estimate of $250.00, and a low estimate of $172.00. Marking an increase of 1.17%, the current average surpasses the previous average price target of $214.38. 
<img src="https://www.benzinga.com/files/images/story/2025/1751925631_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Allstate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$188.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$235.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$197.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>C. Gregory Peters</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Oliver Wintermantel</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$227.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$172.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$228.00</td>
<td>$240.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Allstate. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Allstate compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Allstate's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Allstate's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ALL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Allstate analyst ratings.</a>
<h2>About Allstate</h2>
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
<h3>Allstate: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Allstate's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.91% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Allstate's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.44%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Allstate's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.87%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Allstate's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.5%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.4, caution is advised due to increased financial risk.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Allstate: Insights From 8 Financial Analysts

Across the recent three months, 7 analysts have shared their insights on Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $46.14, with a high estimate of $57.00 and a low estimate of $40.00. Marking an increase of 2.85%, the current average surpasses the previous average price target of $44.86. 
<img src="https://www.benzinga.com/files/images/story/2025/1751925623_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Antero Resources by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$43.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$47.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$57.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$49.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$44.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Antero Resources. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Antero Resources compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Antero Resources's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Antero Resources's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Antero Resources analyst ratings.</a>
<h2>Unveiling the Story Behind Antero Resources</h2>
Antero Resources, based in Denver, engages in the exploration for and production of natural gas and natural gas liquids in the United States and Canada. At the end of 2024, the company reported proven reserves of 17.9 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,424 million cubic feet of equivalent a day in 2024 at a ratio of 35% liquids and 65% natural gas.
<h3>Breaking Down Antero Resources's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Antero Resources displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 31.68%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Antero Resources's net margin excels beyond industry benchmarks, reaching 14.93%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Antero Resources's ROE stands out, surpassing industry averages. With an impressive ROE of 2.92%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Antero Resources's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.6% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Antero Resources's debt-to-equity ratio is below the industry average at 0.53, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Antero Resources Through The Eyes Of 7 Analysts

In the current session, the stock is trading at $318.50, after a 2.12% increase. Over the past month, Constellation Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) stock increased by 9.36%, and in the past year, by 47.37%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1751925617_0.png" alt="Past Year Chart" />

<h3>Evaluating Constellation Energy P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 18.78 in the Electric Utilities industry, Constellation Energy Inc. has a higher P/E ratio of 32.86. Shareholders might be inclined to think that Constellation Energy Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751925617_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for Constellation Energy

During the last three months, 20 analysts shared their evaluations of ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for ON Semiconductor, presenting an average target of $51.35, a high estimate of $72.00, and a low estimate of $34.00. Highlighting a 3.59% decrease, the current average has fallen from the previous average price target of $53.26. 
<img src="https://www.benzinga.com/files/images/story/2025/1751925616_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of ON Semiconductor by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher Danely</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Pradeep Ramani</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$72.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Neutral</td>
<td>$55.00</td>
<td>-</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$56.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Suji Desilva</td>
<td>Roth Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Adjusts</td>
<td>Outperform</td>
<td>$52.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Gary Mobley</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$48.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Tristan Gerra</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$50.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Kevin Cassidy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$50.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Pradeep Ramani</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$41.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Tore Svanberg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$42.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Christopher Danely</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to ON Semiconductor. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ON Semiconductor compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of ON Semiconductor's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of ON Semiconductor's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ON/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ON Semiconductor analyst ratings.</a>
<h2>All You Need to Know About ON Semiconductor</h2>
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.
<h3>Key Indicators: ON Semiconductor's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: ON Semiconductor's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -22.39%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: ON Semiconductor's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -33.62%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): ON Semiconductor's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -5.78%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): ON Semiconductor's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -3.56%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.42, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For ON Semiconductor's Future

Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has outperformed the market over the past 15 years by 17.54% on an annualized basis producing an average annual return of 29.79%. Currently, Strategy has a market capitalization of $110.49 billion. 
Buying $100 In MSTR: If an investor had bought $100 of MSTR stock 15 years ago, it would be worth $5,123.93 today based on a price of $395.55 for MSTR at the time of writing.
<h3>Strategy's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751925614_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSTR

$100 Invested In Strategy 15 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-07-07/apple-loses-its-top-ai-models-executive-to-meta-s-hiring-spree?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-07/apple-loses-its-top-ai-models-executive-to-meta-s-hiring-spree?embedded-checkout=true</a>

AAPL

'Apple Loses Its Top AI Models Executive to Meta's Hiring Spree'- Bloomberg

<a href="https://www.whitehouse.gov/presidential-actions/2025/07/ending-market-distorting-subsidies-for-unreliable-foreign%e2%80%91controlled-energy-sources/">https://www.whitehouse.gov/presidential-actions/2025/07/ending-market-distorting-subsidies-for-unreliable-foreign%e2%80%91controlled-energy-sources/</a>

Macro Notification

President Trump Signs Executive Order Aiming To End Subsidies For Foreign Controlled Energy Sources

<a href="https://www.whitehouse.gov/presidential-actions/2025/07/extending-the-modification-of-the-reciprocal-tariff-rates/">https://www.whitehouse.gov/presidential-actions/2025/07/extending-the-modification-of-the-reciprocal-tariff-rates/</a>

President Trump Signs Executive Order Extending Tariff Deadline To August 1

Hong Kong, July 07, 2025 (GLOBE NEWSWIRE) -- Masonglory Limited (the "Company"), is a Hong Kong based subcontractor providing wet trades and related ancillary services to private and public sectors, today announced the pricing of its initial public offering (the "Offering") of 1,500,000 ordinary shares (the "Ordinary Shares") at a public offering price of $4.00 per share. The Company expects to receive aggregate gross proceeds of approximately $6 million, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on July 8, 2025 under the ticker symbol "MSGY". The Offering is expected to close on July 9, 2025, subject to the satisfaction of customary closing conditions. In addition, the Company has granted the underwriters an option (the "Over-Allotment Option"), within 45&nbsp;days from the closing date of the Offering, to purchase up to an additional 225,000 Ordinary Shares at the public offering price, less underwriting discounts, to cover the Over-Allotment Option, if any.

IPOs

MSGY

Masonglory Prices IPO Of 1.5M Ordinary Shares At $4/Shr For Total Gross Proceeds Of ~$6M

Contracts

Press Releases

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Offerings

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules

Small Cap

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules

Opinion

After Major Oncology Conference, All Eyes Turn to Industry Innovation

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CTOR

ONCY

TPST

TSX:ONC

AN2 Therapeutics

Aytu BioPharma

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Citius Pharmaceuticals

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Gelteq

Grace Therapeutics

IGC Pharma

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

ProPhase Labs

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

VYNE Therapeutics

D. Boral Capital

HC Wainwright & Co.

EF Hutton

Screenshot 2024-08-06 at 7.17.40 PM

Biotech

TENK

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

Screenshot 2024-07-29 at 8.39.42 PM

From fighting cancer to treating bloodstream infections, Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is busy trying to solve some of the world&#39;s ills. That&#39;s picking up steam with two of its lead products close to commercialization. 

Comments

Citius Pharmaceuticals

Vendite allo scoperto

Citius Pharmaceuticals (NASDAQ:CTXR) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO